[ad_1]
the Vaccine for COVID-19 arriving is safe, because “all the validation and evaluation phases have been respected, no stage was skipped“. After the controversy raised in recent days by the words of Andrea Crisanti, the director of microbiology at the University of Padua who had questioned its safety, now also intervenes Aifa, the Italian Medicines Agency, to ensure that all protocols have been followed, so there are no valid reasons to doubt the efficacy of the vaccine developed by the pharmaceutical companies Pfizer and Moderna.
Interviewed by the National Newspaper, the director of Aifa Nicola Magrini He assured that the last and most important phase of experimentation, phase 3, “involved randomized studies in tens of thousands of people” to evaluate the protective effects and the ability to prevent infections. “In the last few months, 30-40 thousand, even 60 thousand volunteers have been tested,” he explained. Safety with respect to rare adverse events has been extensively verified.. They are vaccines studied according to standards oriented to the registry, it is out of place to think that things were done quickly and badly. Pfizer me Modern they have already announced their results, Astrazeneca will do it at the beginning of December, and it is not a race to finish first, they are concomitant solutions ”.
And, Magrini stressed, the speed in its preparation is not due to the fact that steps have been taken, on the contrary, “there has been an international mobilization never seen before, an exchange of information that opens unimaginable scenarios, the research institutes of the entire world has launched into the business by deploying the most advanced technologies and leading scientists. Vaccines are on the way that can boast a high immune response. “
Regarding the distribution, it will begin gradually: “One, two, then three million a month of different vaccines, They will be kept strictly separate, the important thing will always be to make the call with the same type. We estimate that in the first and second trimesters of next year the accessions to vaccination offered to subjects at risk will be much higher than 75% – Magrini concluded – when we move to mass vaccination, adherence should in any case exceed 70%. Ai Doubts about No Vax we will respond with active pharmacovigilance studies, and an app for those vaccinated, but without forcing anyone ”.
[ad_2]
